---
title: "What to Expect in a Cardiovascular Clinical Trial — Patient Guide | Amavita Research"
url: https://md.amavitaresearch.com/blog/what-to-expect-cardiovascular-clinical-trial
canonical: https://www.amavitaresearch.com/blog/what-to-expect-cardiovascular-clinical-trial
schema_type: Article
last_updated: 2026-05-13
---

# What to Expect in a Cardiovascular Clinical Trial

A patient guide to clinical trial enrollment, visits, and what your rights look like.

## Before you enroll

You'll meet with a research coordinator and the Principal Investigator. They'll explain the trial: what's being studied, what visits look like, what the risks and benefits are, and what alternatives you have. You'll be given an informed consent form to read — at home, with family if you want — and you can ask any question before signing.

The informed consent process is not a one-time event. You can withdraw from the trial at any time, for any reason, without affecting your routine medical care.

## The screening visit

- Physical exam and review of your medical history
- Bloodwork (typically a venous draw)
- ECG (12-lead, takes a few minutes)
- Other tests depending on the trial (echocardiogram, 24-hour blood pressure monitoring, etc.)

The Principal Investigator reviews your screening data and confirms whether you meet the trial's eligibility criteria. Not every screened patient qualifies — and that's a safety feature, not a setback.

## Enrollment and the first dose

If you qualify, you'll be enrolled. The first dose of study drug (or first study procedure) is given at the site under direct PI supervision. You're observed for a defined post-dose period depending on the protocol.

## During the trial

- Trial-specific visits at defined intervals (usually monthly during active phases)
- Routine cardiology care continues with your primary cardiologist
- Trial-related care (study drug, study procedures, study tests) is free
- You're given clear instructions on what symptoms to report and how

## Your rights as a participant

- **Withdraw at any time** — no penalty, no impact on your routine care
- **Be informed of new findings** — if researchers learn something during the trial that could affect your decision to continue, they must tell you
- **Confidentiality** — your data is protected under HIPAA and trial-specific privacy rules
- **Free trial-related care** — including study drug, study procedures, and management of any trial-related side effects
- **24/7 contact** — every trial has a contact number you can call any time

## How long does it last?

Cardiovascular trials typically run 6 months to 3+ years depending on phase and indication. Some trials have an "active treatment" phase followed by long-term follow-up visits.

## After the trial ends

- End-of-study summary sent to your primary cardiologist
- You return to routine cardiology care
- In some trials, you may continue receiving the study drug (open-label extension) if the sponsor offers one
- You may be invited to participate in a long-term follow-up registry

## Common questions

- **Will I get a placebo?** Depends on the trial. The informed consent form tells you the randomization ratio and explains what placebo means in your specific study.
- **Can I leave the trial?** Yes, any time, for any reason.
- **Do I have to stop my regular medications?** Usually no, but the protocol may require dose adjustments. The PI will go over this.
- **Will my insurance be billed?** Trial-related care is free. Routine cardiology care continues to be billed to insurance as normal.

## Key links

- Patient FAQ: https://www.amavitaresearch.com/faq-patients
- Active trials: https://www.amavitaresearch.com/trials
- How to read a consent form: https://www.amavitaresearch.com/blog/how-to-read-a-clinical-trial-consent-form
- Glossary: https://www.amavitaresearch.com/clinical-trial-glossary
- Contact: https://www.amavitaresearch.com/contact-patient · (786) 703-5941